{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:00:40Z","timestamp":1791928840574,"version":"4.3.4"},"reference-count":62,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"8","license":[{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2024,7,23]]},"DOI":"10.1167\/iovs.65.8.37","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T13:53:42Z","timestamp":1721742822000},"page":"37","source":"Crossref","is-referenced-by-count":8,"title":["Protein and mRNA Expression in Uveal Melanoma Cell Lines Are Related to GNA and BAP1 Mutation Status"],"prefix":"10.1167","volume":"65","author":[{"given":"Maria Chiara","family":"Gelmi","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnoud H.","family":"de Ru","sequence":"additional","affiliation":[{"name":"Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"van Veelen","sequence":"additional","affiliation":[{"name":"Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayman T. N.","family":"Tjokrodirijo","sequence":"additional","affiliation":[{"name":"Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc-Henri","family":"Stern","sequence":"additional","affiliation":[{"name":"Inserm U830, DNA Repair and Uveal Melanoma (D.R.U.M.), Institut Curie, PSL Research University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Houy","sequence":"additional","affiliation":[{"name":"Inserm U830, DNA Repair and Uveal Melanoma (D.R.U.M.), Institut Curie, PSL Research University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Verdijk","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ophthalmic Pathology Section, Erasmus MC, Rotterdam, The Netherlands"},{"name":"Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. H. Khanh","family":"Vu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce R.","family":"Ksander","sequence":"additional","affiliation":[{"name":"Schepens Eye Research Institute, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanda","family":"Vaarwater","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Erasmus MC Cancer Institute, Rotterdam, The Netherlands"},{"name":"Department of Ophthalmology, Erasmus MC, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emine","family":"Kilic","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Erasmus MC, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin","family":"Brosens","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Erasmus MC Cancer Institute, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine J.","family":"Jager","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/(ISSN)1097-0215","article-title":"Establishment and characterization of primary and metastatic uveal melanoma cell lines","volume":"66","author":"Luyten","year":"1996","journal-title":"Int J Cancer"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1023\/A:1018479011340","article-title":"Expression of MAGE genes in ocular melanoma during progression from primary to metastatic disease","volume":"15","author":"Chen","year":"1997","journal-title":"Clin Exp Metastasis"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1016\/j.molonc.2014.06.004","article-title":"Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target","volume":"8","author":"Amirouchene-Angelozzi","year":"2014","journal-title":"Mol Oncol"},{"key":"bib4","first-page":"T5","article-title":"Uveal melanoma cell lines: where do they come from? (An American Ophthalmological Society Thesis)","volume":"114","author":"Jager","year":"2016","journal-title":"Trans Am Ophthalmol Soc"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.1167\/iovs.08-2324","article-title":"Authenticating cell lines in ophthalmic research laboratories","volume":"49","author":"Folberg","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib6","first-page":"829","article-title":"Characterization of uveal melanoma cell lines that grow as xenografts in rabbit eyes","volume":"30","author":"Kan-Mitchell","year":"1989","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"42409","DOI":"10.1074\/jbc.M308709200","article-title":"Mutation of B-Raf in human choroidal melanoma cells mediates cell proliferation and transformation through the MEK\/ERK pathway","volume":"278","author":"Calipel","year":"2003","journal-title":"J Biol Chem"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/01.cmr.0000130006.46885.a0","article-title":"The RAS-BRAF kinase pathway is not involved in uveal melanoma","volume":"14","author":"Kilic","year":"2004","journal-title":"Melanoma Res"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1167\/iovs.07-0722","article-title":"Pyrophosphorolysis detects B-RAF mutations in primary uveal melanoma","volume":"49","author":"Maat","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/pcr.2012.25.issue-2","article-title":"Genetic and molecular characterization of uveal melanoma cell lines","volume":"25","author":"Griewank","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/ijc.v142.3","article-title":"Authentication of M14 melanoma cell line proves misidentification of MDA-MB-435 breast cancer cell line","volume":"142","author":"Korch","year":"2018","journal-title":"Int J Cancer"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nature07586","article-title":"Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi","volume":"457","author":"Van Raamsdonk","year":"2009","journal-title":"Nature"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1056\/NEJMoa1000584","article-title":"Mutations in GNA11 in uveal melanoma","volume":"363","author":"Van Raamsdonk","year":"2010","journal-title":"N Engl J Med"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/ijc.v62:2","article-title":"Establishment and characterization of an uveal-melanoma cell line","volume":"62","author":"De Waard-Siebinga","year":"1995","journal-title":"Int J Cancer"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/(ISSN)1097-0215","article-title":"Melanomas that develop within the eye inhibit lymphocyte proliferation","volume":"73","author":"Verbik","year":"1997","journal-title":"Int J Cancer"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","article-title":"The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences","volume":"50","author":"Perez-Riverol","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41586-022-04558-8","article-title":"A joint NCBI and EMBL-EBI transcript set for clinical genomics and research","volume":"604","author":"Morales","year":"2022","journal-title":"Nature"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"W102","DOI":"10.1093\/nar\/gky406","article-title":"Mutalisk: a web-based somatic MUTation AnaLyIS toolKit for genomic, transcriptional and epigenomic signatures","volume":"46","author":"Lee","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"btad756","DOI":"10.1093\/bioinformatics\/btad756","article-title":"Assigning mutational signatures to individual samples and individual somatic mutations with SigProfilerAssignment","volume":"39","author":"Diaz-Gay","year":"2023","journal-title":"Bioinformatics"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"113132","DOI":"10.1016\/j.celrep.2023.113132","article-title":"Multi-omics comparison of malignant and normal uveal melanocytes reveals molecular features of uveal melanoma","volume":"42","author":"Gentien","year":"2023","journal-title":"Cell Rep"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.7171\/jbt.18-2902-002","article-title":"The Cellosaurus, a cell-line knowledge resource","volume":"29","author":"Bairoch","year":"2018","journal-title":"J Biomol Tech"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ccell.2017.07.003","article-title":"Integrative analysis identifies four molecular and clinical subsets in uveal melanoma","volume":"32","author":"Robertson","year":"2017","journal-title":"Cancer Cell"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.3390\/cancers11081200","article-title":"SRSF2 mutations in uveal melanoma: a preference for in-frame deletions?","volume":"11","author":"van Poppelen","year":"2019","journal-title":"Cancers (Basel)"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/php.2015.91.issue-1","article-title":"UV signature mutations","volume":"91","author":"Brash","year":"2015","journal-title":"Photochem Photobiol"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic classification of cutaneous melanoma","volume":"161","author":"Cancer Genome Atlas Network","year":"2015","journal-title":"Cell"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nature22071","article-title":"Whole-genome landscapes of major melanoma subtypes","volume":"545","author":"Hayward","year":"2017","journal-title":"Nature"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","article-title":"The repertoire of mutational signatures in human cancer","volume":"578","author":"Alexandrov","year":"2020","journal-title":"Nature"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1167\/iovs.04-0961","article-title":"Uveal and cutaneous melanoma: shared expression characteristics of melanoma-associated antigens","volume":"46","author":"van Dinten","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/ng1412","article-title":"Effects of G-protein mutations on skin color","volume":"36","author":"Van Raamsdonk","year":"2004","journal-title":"Nat Genet"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"5492","DOI":"10.18632\/oncotarget.v9i4","article-title":"Exon 3 mutations of CTNNB1 drive tumorigenesis: a review","volume":"9","author":"Gao","year":"2018","journal-title":"Oncotarget"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1126\/science.8259518","article-title":"Association of the APC gene product with \u00df-catenin","volume":"262","author":"Rubinfeld","year":"1993","journal-title":"Science"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1126\/science.272.5264.1023","article-title":"Binding of GSK3\u00df to the APC-\u00df-catenin complex and regulation of complex assembly","volume":"272","author":"Rubinfeld","year":"1996","journal-title":"Science"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1126\/science.275.5307.1784","article-title":"Constitutive transcriptional activation by a \u00df-catenin-Tcf complex in APC\u2013\/\u2013 colon carcinoma","volume":"275","author":"Korinek","year":"1997","journal-title":"Science"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1126\/science.275.5307.1787","article-title":"Activation of \u00df-catenin-Tcf signaling in colon cancer by mutations in \u00df-catenin or APC","volume":"275","author":"Morin","year":"1997","journal-title":"Science"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"7219","DOI":"10.1038\/sj.onc.1203181","article-title":"Dysregulated expression of \u00df-catenin marks early neoplastic change in Apc mutant mice, but not all lesions arising in Msh2 deficient mice","volume":"18","author":"Kongkanuntn","year":"1999","journal-title":"Oncogene"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1158\/0008-5472.CAN-12-1394","article-title":"PNUTS functions as a proto-oncogene by sequestering PTEN","volume":"73","author":"Kavela","year":"2013","journal-title":"Cancer Res"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.1038\/s41467-018-05660-0","article-title":"MYC dephosphorylation by the PP1\/PNUTS phosphatase complex regulates chromatin binding and protein stability","volume":"9","author":"Dingar","year":"2018","journal-title":"Nat Commun"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"7050146","DOI":"10.1155\/2020\/7050146","article-title":"Upregulation of phosphatase 1 nuclear-targeting subunit (PNUTS) is an independent predictor of poor prognosis in prostate cancer","volume":"2020","author":"Marx","year":"2020","journal-title":"Dis Markers"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1091\/mbc.e15-04-0218","article-title":"LIMCH1 regulates nonmuscle myosin-II activity and suppresses cell migration","volume":"28","author":"Lin","year":"2017","journal-title":"Mol Biol Cell"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"143963","DOI":"10.1016\/j.gene.2019.143963","article-title":"LIMCH1 suppress the growth of lung cancer by interacting with HUWE1 to sustain p53 stability","volume":"712","author":"Zhang","year":"2019","journal-title":"Gene"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"181","DOI":"10.7150\/jca.47883","article-title":"Loss of LIMCH1 predicts poor prognosis in patients with surgically resected lung adenocarcinoma: a study based on immunohistochemical analysis and bioinformatics","volume":"12","author":"Cao","year":"2021","journal-title":"J Cancer"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1158\/2159-8290.CD-12-0361","article-title":"ARID1A mutations in cancer: another epigenetic tumor suppressor?","volume":"3","author":"Wu","year":"2013","journal-title":"Cancer Discov"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"776","DOI":"10.7150\/jca.41296","article-title":"Pan-cancer analysis of ARID1A alterations as biomarkers for immunotherapy outcomes","volume":"11","author":"Jiang","year":"2020","journal-title":"J Cancer"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s11060-015-2052-2","article-title":"Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system","volume":"127","author":"van de Nes","year":"2016","journal-title":"J Neurooncol"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.3390\/cancers14092090","article-title":"Genetic and clinical characteristics of ARID1A mutated melanoma reveal high tumor mutational load without implications on patient survival","volume":"14","author":"Thielmann","year":"2022","journal-title":"Cancers (Basel)"},{"key":"bib50","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nature11308","article-title":"Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors","volume":"488","author":"Koo","year":"2012","journal-title":"Nature"},{"key":"bib51","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nature11019","article-title":"ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner","volume":"485","author":"Hao","year":"2012","journal-title":"Nature"},{"key":"bib52","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1101\/gad.235473.113","article-title":"The R-spondin\/Lgr5\/Rnf43 module: regulator of Wnt signal strength","volume":"28","author":"de Lau","year":"2014","journal-title":"Genes Dev"},{"key":"bib53","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/ng.3127","article-title":"RNF43 is frequently mutated in colorectal and endometrial cancers","volume":"46","author":"Giannakis","year":"2014","journal-title":"Nat Genet"},{"key":"bib54","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/ng.2983","article-title":"Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer","volume":"46","author":"Wang","year":"2014","journal-title":"Nat Genet"},{"key":"bib55","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1158\/1078-0432.CCR-21-3018","article-title":"Comprehensive analysis of R-spondin fusions and RNF43 mutations implicate novel therapeutic options in colorectal cancer","volume":"28","author":"Seeber","year":"2022","journal-title":"Clin Cancer Res"},{"key":"bib56","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1038\/s41591-022-01976-z","article-title":"RNF43 mutations predict response to anti-BRAF\/EGFR combinatory therapies in BRAFV600E metastatic colorectal cancer","volume":"28","author":"Elez","year":"2022","journal-title":"Nat Med"},{"key":"bib57","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1038\/s41467-022-30794-7","article-title":"RNF43 G659fs is an oncogenic colorectal cancer mutation and sensitizes tumor cells to PI3K\/mTOR inhibition","volume":"13","author":"Fang","year":"2022","journal-title":"Nat Commun"},{"key":"bib58","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/ng1980","article-title":"Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum","volume":"39","author":"Stevanin","year":"2007","journal-title":"Nat Genet"},{"key":"bib59","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1212\/01.wnl.0000294327.66106.3d","article-title":"SPG11 mutations are common in familial cases of complicated hereditary spastic paraplegia","volume":"70","author":"Paisan-Ruiz","year":"2008","journal-title":"Neurology"},{"key":"bib60","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1093\/brain\/aww111","article-title":"Genetic and phenotypic characterization of complex hereditary spastic paraplegia","volume":"139","author":"Kara","year":"2016","journal-title":"Brain"},{"key":"bib61","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/ana.v79.4","article-title":"Hereditary spastic paraplegia: clinicogenetic lessons from 608 patients","volume":"79","author":"Sch\u00fcle","year":"2016","journal-title":"Ann Neurol"},{"key":"bib62","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.3390\/cancers11081104","article-title":"Differential expression of DNA repair genes in prognostically-favorable versus unfavorable uveal melanoma","volume":"11","author":"Dogrus\u00f6z","year":"2019","journal-title":"Cancers (Basel)"},{"key":"bib18","author":"Korotkevich"},{"key":"bib31","first-page":"89","article-title":"Molecular cytogenetic characterization of ten uveal melanoma cell lines","volume-title":"Uveal Melanoma: A Model for Exploring Fundamental Cancer Biology","author":"Director-Myska","year":"2004"}],"container-title":["Investigative Ophthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2800608","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:31:53Z","timestamp":1791927113000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2800608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,23]]},"references-count":62,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,7,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.65.8.37","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,23]]}}}